Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation; Phase 2 Trial Of EPI-7386 in Combination With Enzalutamide To Initiate In Calendar 3Q23

Author: Happy Mohamed | August 14, 2023 12:12pm

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_08142023_EPIX_Bautz.pdf

Posted In: EPIX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist